These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7086805)

  • 1. Calcium metabolism during rifampicin and isoniazid therapy for tuberculosis.
    Perry W; Erooga MA; Brown J; Stamp TC
    J R Soc Med; 1982 Jul; 75(7):533-6. PubMed ID: 7086805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteomalacia during rifampicin and isoniazid therapy is rare in Hong Kong.
    Chan TY
    Int J Clin Pharmacol Ther; 1996 Dec; 34(12):533-4. PubMed ID: 8996847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium metabolism during rifampicin and isoniazid therapy for tuberculosis.
    Brodie MJ; Hillyard CJ
    J R Soc Med; 1982 Nov; 75(11):919. PubMed ID: 7143346
    [No Abstract]   [Full Text] [Related]  

  • 4. [Course of serum alkaline phosphatase during treatment with isoniazid and rifampicin].
    Toppet M; Vainsel M; Cantraine F; Franckson M
    Arch Fr Pediatr; 1985 Feb; 42(2):79-80. PubMed ID: 4004474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium metabolism during rifampicin and isoniazid therapy.
    Perry W
    Tubercle; 1983 Mar; 64(1):57-8. PubMed ID: 6845435
    [No Abstract]   [Full Text] [Related]  

  • 6. Lymphocyte transformation test for the evaluation of adverse effects of antituberculous drugs.
    Schreiber J; Zissel G; Greinert U; Schlaak M; Müller-Quernheim J
    Eur J Med Res; 1999 Feb; 4(2):67-71. PubMed ID: 10066642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long term study of the effect of rifampicin and isoniazid on vitamin D metabolism.
    Williams SE; Wardman AG; Taylor GA; Peacock M; Cooke NJ
    Tubercle; 1985 Mar; 66(1):49-54. PubMed ID: 3838603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term efficacy of 6-month therapy with isoniazid and rifampin compared with isoniazid, rifampin, and pyrazinamide treatment for pleural tuberculosis.
    García-Rodríguez JF; Valcarce-Pardeiro N; Álvarez-Díaz H; Mariño-Callejo A
    Eur J Clin Microbiol Infect Dis; 2019 Nov; 38(11):2121-2126. PubMed ID: 31377953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatotoxicity due to rifampicin, isoniazid and pyrazinamide in patients with tuberculosis: is anti-HCV a risk factor?
    Nader LA; de Mattos AA; Picon PD; Bassanesi SL; De Mattos AZ; Pineiro Rodriguez M
    Ann Hepatol; 2010; 9(1):70-4. PubMed ID: 20308724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatotoxicity of rifampin-pyrazinamide and isoniazid preventive therapy and tuberculosis treatment.
    van Hest R; Baars H; Kik S; van Gerven P; Trompenaars MC; Kalisvaart N; Keizer S; Borgdorff M; Mensen M; Cobelens F
    Clin Infect Dis; 2004 Aug; 39(4):488-96. PubMed ID: 15356811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum total bile acid levels in patients receiving rifampicin and isoniazid.
    Berg JD; Pandov HI; Sammons HG
    Ann Clin Biochem; 1984 May; 21 ( Pt 3)():218-22. PubMed ID: 6476775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of rifampicin with and without isoniazid in rheumatoid arthritis.
    McConkey B; Situnayake RD
    J Rheumatol; 1988 Jan; 15(1):46-50. PubMed ID: 3351840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS, the Adult AIDS Clinical Trials Group, the Pan American Health Organization, and the Centers for Disease Control and Prevention Study Group.
    Gordin F; Chaisson RE; Matts JP; Miller C; de Lourdes Garcia M; Hafner R; Valdespino JL; Coberly J; Schechter M; Klukowicz AJ; Barry MA; O'Brien RJ
    JAMA; 2000 Mar; 283(11):1445-50. PubMed ID: 10732934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberculous pleural effusion: experience with six months of treatment with isoniazid and rifampicin.
    Cañete C; Galarza I; Granados A; Farrero E; Estopà R; Manresa F
    Thorax; 1994 Nov; 49(11):1160-1. PubMed ID: 7831634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic toxicity in South Indian patients during treatment of tuberculosis with short-course regimens containing isoniazid, rifampicin and pyrazinamide.
    Parthasarathy R; Sarma GR; Janardhanam B; Ramachandran P; Santha T; Sivasubramanian S; Somasundaram PR; Tripathy SP
    Tubercle; 1986 Jun; 67(2):99-108. PubMed ID: 3775870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermittent chemotherapy of pulmonary tuberculosis using rifampicin and isoniazid for primary treatment: the influence of various factors on the frequency of side-effects.
    Eule H; Werner E; Winsel K; Iwainsky H
    Tubercle; 1974 Mar; 55(1):81-9. PubMed ID: 4620295
    [No Abstract]   [Full Text] [Related]  

  • 17. Cerebral hemorrhage associated with vitamin K deficiency in congenital tuberculosis treated with isoniazid and rifampin.
    Kobayashi K; Haruta T; Maeda H; Kubota M; Nishio T
    Pediatr Infect Dis J; 2002 Nov; 21(11):1088-90. PubMed ID: 12458578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Toxic hepatitis caused by rifampin and isoniazid in treatment of tuberculosis (author's transl)].
    Abeledo Mezquita G; Otero Reigada MC
    An Esp Pediatr; 1977 Feb; 10(2):167-70. PubMed ID: 869341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse events in adults with latent tuberculosis infection receiving daily rifampicin or isoniazid: post-hoc safety analysis of two randomised controlled trials.
    Campbell JR; Trajman A; Cook VJ; Johnston JC; Adjobimey M; Ruslami R; Eisenbeis L; Fregonese F; Valiquette C; Benedetti A; Menzies D
    Lancet Infect Dis; 2020 Mar; 20(3):318-329. PubMed ID: 31866327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rifampicin in the treatment of active pulmonary tuberculosis. Controlled trial of isoniazid-rifampicin-thiocarlide versus isoniazid-streptomycin-thiocarlide in untreated tuberculosis. Treatment of relapses with the combination rifampicin-ethambutol-thiocarlide].
    Chioléro R
    Schweiz Med Wochenschr; 1974 Mar; 104(10):356-64. PubMed ID: 4206521
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.